Cytozyme-F
Natural health product licensed in Canada
- Licence holder
- Biotics Research Corporation
- NPN or DIN-HM
- 80046234
- Status
- Active licence
- Licence date
- 18 November 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Pisum Sativum - whole | 20 mcg | Not calculated |
| Peroxyde d'hydrogène: oxydo-réductase de peroxyde d'hydrogène Source : Pisum Sativum - whole | 0.045 Unité "Baker" du FCC | Not calculated |
Non-medicinal ingredients
Cellulose, Acide stéarique, Stéarate de magnésium, Glaçure pharmaceutique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Contains catalase, a digestive enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity has been known to occur, in which case, discontinue use.
- Contre-indications
Do no use if you have gout or in cases of leukocytosis.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80046234
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.